68Ga-PSMA PET/CT for Detection of Recurrent Prostate Cancer After Initial Therapy
Phase of Trial: Phase II/III
Latest Information Update: 19 Jun 2018
At a glance
- Drugs Gallium 68 PSMA (Primary)
- Indications Adenocarcinoma; Prostate cancer
- Focus Diagnostic use
- 08 Jun 2018 Planned number of patients changed from 200 to 600.
- 05 Jun 2018 Preliminary results presented at the 54th Annual Meeting of the American Society of Clinical Oncology
- 21 May 2018 Results (n=6) of case series comparing of the two tests in men with BCR of CaP, were presented at the 113th Annual Meeting of the American Urological Association.